An in vivo safety and efficacy model for T-cell engagers

Dr. Vincent Muczynski, Research Associate at University College London, presents an in vivo safety and efficacy model for T-cell engagers using adeno-associated virus (AAV) vectors. Explore some of the humanized mouse models available to determine toxicity and efficacy on the path to the clinic.

This video was filmed in partnership with The Jackson Laboratory.